2 Listed Companies, Bangladesh Export Import Company (Beximco) Limited & Beximco Pharmaceuticals Limited & Orion Infusion Limited discloses their third-quarter financials for the year ended (January 2024 – March 2024). This source is known from DSE.
Beximco: The company’s earnings per share (EPS) was Tk 0.86 paisa in Q3 of the current financial year (January – March 24). EPS was Tk 1.22 paisa during the same period last year. NAV per share was Tk. 94.83 on March 31, 2024.
Beximco Pharma: The company’s earnings per share (EPS) was Tk 3.06 paisa in Q3 of the current financial year (January – March 24). EPS was Tk 2.13 paisa during the same period last year. NAV per share was Tk. 104.17 on March 31, 2024.
Share this
